Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 107

1.

Examining naltrexone and alcohol effects in a minority population: results from an initial human laboratory study.

Plebani JG, Oslin DW, Lynch KG.

Am J Addict. 2011 Jul-Aug;20(4):330-6. doi: 10.1111/j.1521-0391.2011.00138.x. Epub 2011 May 31.

PMID:
21679264
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Naltrexone effects on alcohol consumption in a clinical laboratory paradigm: temporal effects of drinking.

Anton RF, Drobes DJ, Voronin K, Durazo-Avizu R, Moak D.

Psychopharmacology (Berl). 2004 Apr;173(1-2):32-40. Epub 2004 Jan 14.

PMID:
14722705
[PubMed - indexed for MEDLINE]
3.

Serum 6-beta-naltrexol levels are related to alcohol responses in heavy drinkers.

McCaul ME, Wand GS, Rohde C, Lee SM.

Alcohol Clin Exp Res. 2000 Sep;24(9):1385-91.

PMID:
11003204
[PubMed - indexed for MEDLINE]
4.

Efficacy of extended-release naltrexone in patients with relatively higher severity of alcohol dependence.

Pettinati HM, Silverman BL, Battisti JJ, Forman R, Schweizer E, Gastfriend DR.

Alcohol Clin Exp Res. 2011 Oct;35(10):1804-11. doi: 10.1111/j.1530-0277.2011.01524.x. Epub 2011 May 16.

PMID:
21575016
[PubMed - indexed for MEDLINE]
5.

Non-specific effect of naltrexone on ethanol consumption in social drinkers.

de Wit H, Svenson J, York A.

Psychopharmacology (Berl). 1999 Sep 1;146(1):33-41.

PMID:
10485962
[PubMed - indexed for MEDLINE]
6.

Behavioral responses to ethanol in light and moderate social drinkers following naltrexone pretreatment.

Doty P, Kirk JM, Cramblett MJ, de Wit H.

Drug Alcohol Depend. 1997 Aug 25;47(2):109-16.

PMID:
9298332
[PubMed - indexed for MEDLINE]
7.

Naltrexone alters subjective and psychomotor responses to alcohol in heavy drinking subjects.

McCaul ME, Wand GS, Eissenberg T, Rohde CA, Cheskin LJ.

Neuropsychopharmacology. 2000 May;22(5):480-92.

PMID:
10731623
[PubMed - indexed for MEDLINE]
Free Article
8.

Effects of naltrexone and nalmefene on subjective response to alcohol among non-treatment-seeking alcoholics and social drinkers.

Drobes DJ, Anton RF, Thomas SE, Voronin K.

Alcohol Clin Exp Res. 2004 Sep;28(9):1362-70.

PMID:
15365307
[PubMed - indexed for MEDLINE]
9.

Pharmacokinetics, safety, and tolerability of a depot formulation of naltrexone in alcoholics: an open-label trial.

Galloway GP, Koch M, Cello R, Smith DE.

BMC Psychiatry. 2005 Apr 1;5:18.

PMID:
15804355
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

The status of naltrexone in the treatment of alcohol dependence: specific effects on heavy drinking.

Pettinati HM, O'Brien CP, Rabinowitz AR, Wortman SP, Oslin DW, Kampman KM, Dackis CA.

J Clin Psychopharmacol. 2006 Dec;26(6):610-25. Review.

PMID:
17110818
[PubMed - indexed for MEDLINE]
11.

Potentiation of low dose ketamine effects by naltrexone: potential implications for the pharmacotherapy of alcoholism.

Krystal JH, Madonick S, Perry E, Gueorguieva R, Brush L, Wray Y, Belger A, D'Souza DC.

Neuropsychopharmacology. 2006 Aug;31(8):1793-800. Epub 2006 Jan 4.

PMID:
16395307
[PubMed - indexed for MEDLINE]
Free Article
12.

Targeted versus daily naltrexone: secondary analysis of effects on average daily drinking.

Hernandez-Avila CA, Song C, Kuo L, Tennen H, Armeli S, Kranzler HR.

Alcohol Clin Exp Res. 2006 May;30(5):860-5.

PMID:
16634855
[PubMed - indexed for MEDLINE]
13.

A clinical laboratory paradigm for evaluating medication effects on alcohol consumption: naltrexone and nalmefene.

Drobes DJ, Anton RF, Thomas SE, Voronin K.

Neuropsychopharmacology. 2003 Apr;28(4):755-64. Epub 2002 Oct 30.

PMID:
12655322
[PubMed - indexed for MEDLINE]
Free Article
14.

Effects of naltrexone on alcohol sensitivity and genetic moderators of medication response: a double-blind placebo-controlled study.

Ray LA, Hutchison KE.

Arch Gen Psychiatry. 2007 Sep;64(9):1069-77.

PMID:
17768272
[PubMed - indexed for MEDLINE]
15.

Efficacy and tolerability of long-acting injectable naltrexone for alcohol dependence: a randomized controlled trial.

Garbutt JC, Kranzler HR, O'Malley SS, Gastfriend DR, Pettinati HM, Silverman BL, Loewy JW, Ehrich EW; Vivitrex Study Group.

JAMA. 2005 Apr 6;293(13):1617-25. Erratum in: JAMA. 2005 Jun 15:293(23):2864. JAMA. 2005 Apr 27;293(16):1978.

PMID:
15811981
[PubMed - indexed for MEDLINE]
16.

Open-label pilot study of extended-release naltrexone to reduce drinking and driving among repeat offenders.

Lapham SC, McMillan GP.

J Addict Med. 2011 Sep;5(3):163-9. doi: 10.1097/ADM.0b013e3181eb3b89.

PMID:
21844831
[PubMed - indexed for MEDLINE]
17.

Effect of naltrexone on subjective alcohol response in subjects at high and low risk for future alcohol dependence.

King AC, Volpicelli JR, Frazer A, O'Brien CP.

Psychopharmacology (Berl). 1997 Jan;129(1):15-22.

PMID:
9122358
[PubMed - indexed for MEDLINE]
18.

Effects of naltrexone during the descending limb of the blood alcohol curve.

Ray LA, Hutchison KE, MacKillop J, Miranda R Jr, Audette A, Swift R, Monti PM.

Am J Addict. 2008 Jul-Aug;17(4):257-64. doi: 10.1080/10550490802138400.

PMID:
18612879
[PubMed - indexed for MEDLINE]
19.

Naltrexone decreases craving and alcohol self-administration in alcohol-dependent subjects and activates the hypothalamo-pituitary-adrenocortical axis.

O'Malley SS, Krishnan-Sarin S, Farren C, Sinha R, Kreek MJ.

Psychopharmacology (Berl). 2002 Feb;160(1):19-29. Epub 2002 Jan 22.

PMID:
11862370
[PubMed - indexed for MEDLINE]
20.

Early treatment response in alcohol dependence with extended-release naltrexone.

Ciraulo DA, Dong Q, Silverman BL, Gastfriend DR, Pettinati HM.

J Clin Psychiatry. 2008 Feb;69(2):190-5.

PMID:
18348601
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk